VYGR Operating Cash Flow (Statement)
Voyager Therapeutics Inc · Operating Cash Flow (Statement)
VYGR Operating Cash Flow (Statement)
Latest reported-$120.57Mperiod ending
VYGR Cash from Operations (-$5.45M → -$120.57M)
Annual operating cash flow (statement)
High-resolution chart · PNG
VYGR operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -132,467,000 | |
| -15,310,000 | |
| 77,919,000 | |
| -12,509,000 | |
| -53,525,000 | |
| -96,716,000 | |
| 48,666,000 | |
| -15,887,000 | |
| -61,350,000 | |
| -42,482,000 | |
| 41,299,000 | |
| -11,918,000 | |
| -5,450,000 |